ESG data

Data of ESG(Environment, Society, and Governance) on Meiji Group 's sustainability activities.

Environment

FYE 3/2015 FYE 3/2016 FYE 3/2017
Environmental investments
Environmental protection investments *1 ¥ million 698 621
Extent of impact mitigation of environmental impacts of products *1 ¥ million 285 237
Environmental manegement
Third-party certification Food segment ISO 14001 : Multisite
Eco-Action 21 : Eight group companies
Pharmaceutical segment ISO 14001 : Two plants, one reseach laboratory
FYE 3/2015 FYE 3/2016 FYE 3/2017
Low carbon society
Energy consumption *2 oil:10kL 25.3 24.9 24.5
GJ(gigajoule) 946.2
CO2 emissions(Scope1、Scope2) *2 ten thousands of tons 56.0 55.0 63.8
Eco-car cars 460 549 629
Solar power CO2 emissions t-CO2 122 609 590
Recycling society
Raw materials *2 ten thousands of tons 171 158 224
Total waste *2 ten thousands of tons 7.4 7.6 5.4
Recycling volume *2 ten thousands of tons 3.3 3.3 5.1
Water
Total water used *2 thousands of ㎥ 20,148 18,351 24,104
Discharged water *2 thousands of ㎥ 16,504 16,073 20,255
Biodiversity
Policy of biodiversity conservation We state at section 4 of Meiji environmental policy.
Operational sites owned, leased, managed in, or adjacent to, protected areas and areas of high biodiversity value outside protected areas We jointly established a bird sanctuary in the Nemuro Nature Conservation Area, which we own, in Nemuro-shi, Hokkaido. In the conservation area, our employees volunteer to protect the environment.
Appropriate management of chemical substances
PRTR emissions *2 tons 99.1 9.8 15.1
PRTR transfer volume *2 tons 257.4 403.1 625.8
NOx emissions *2 tons 246 240 139
SOx emissions *2 tons 83 88 76

* The information in environment section concerns Meiji Group including consolidated subsidiaries in Japan.

*1 Environment figures are the sum of figures for Meiji Co., Ltd., and Meiji Seika pharma Co., Ltd.

*2 Figures at FYE March 2015 and FYE March 2016 are the sum of figures for Meiji Co., Ltd., and Meiji Seika pharma Co., Ltd.

Social Area

FYE 3/2015 FYE 3/2016 FYE 3/2017
Number of employees trained in human rights policy *3 persons 375
Number of employees *4 persons 8,594 8,546 8,517
Average number of consecutive years served years 15.1 16.1 16.1
Average age of employees age 38.1 39.0 39.1
Turnover rate(less than 3 years for new graduates) % 8.2 6.4 9.5
New employees persons 197 196 244
Employee training expenses 100 million ¥ 3.04
Employees rate for people with disabilities % 2.13 2.10 2.10
Number seeking reemployment persons 54 72 128
Percentage of applicants reemployed % 100 100 100
Overtime work(per employee) times/months 11.9 11.9 12.5
Percentage of paid vacation taken(days taken/dais granted) % 51.8 52.5 56.8
Child care leave Female persons 153 169 178
Male 25 24 24
Shortened working hours for child purposes Female persons 112 161 200
Male 0 1 2
Return to work rates % 100 100 100
Number of employees taking nursing-careleave persons 5 5 6
Number of volunteer breaks taken persons 8 7 3
Union participation rate *5 % 100 100 100
Frequency rate of lost-worktime injuries (permanent employment basis, Japan) *6 0.42
FYE 3/2017
Food and nutrition seminars times about 2,900
persons about 138,000
Plant tours persons about 170,000
Accreditation in animal testing Yes

*The information of employees in society section concerns regular, direct employees of
Meiji Holdings Co., Ltd., Meiji Co., Ltd., and Meiji Seika Pharma Co., Ltd.
*3 The information concerns new employees and promoted employees of Meiji Holdings Co., Ltd., Meiji Co., Ltd., and Meiji Seika Pharma Co., Ltd.
*4 Employees: regular, direct employees in Japan
*5 We adopt union shop. Employees excluding the management level of Meiji Holdings Co., Ltd.,
Meiji Co., Ltd., and Meiji Seika Pharma Co., Ltd.
*6 Coverage:Plants and research laboratories in Japan (excluding Meiji Feed Co., Ltd., and OHKURA Pharmaceutical Co., Ltd.)
Frequency rate of lost-worktime injuries:Lost-worktime accidents÷total labor hours×1 million

Governance

FYE 3/2017
Independence of Board of Directors
Number of Board of Directors Internal directors Male persons 7
Female 0
Total 7
Independent outside directors Male 2
Female 1
Total 3
Total 10
Rate of independent outside directors on the Board % 30
Number of Board meetings times 13
Board Meeting attendance % 99
Attendance of outside directors at Board meeting % 97
Audit & Supervisory Board
Number of Audit & Supervisory Board Members Internal Audit & Supervisory Board Members Male persons 2
Female 0
Total 2
Independent outside Audit & Supervisory Board Members Male 1
Female 1
Total 2
Total 4
Number of Audit Committee meetings times 15
Audit Committee meeting attendance % 100
Attendance of Independent outside Auditors at Board meetings % 100
Nomination Committee
Number of Nomination Committee Members Internal directors Male persons 1
Female 0
Total 1
Independent outside directors Male 2
Female 1
Total 3
Total 4
Chairperson of Nomination Committee Internal director
FYE 3/2017
Compensation of Directors Auditors *7
Position Number of persons provided with compensation Compensation(million ¥)
Director (excluding outside directors) 9 367
Auditor & Supervisory Board Members (excluding outside Audit & Supervisory Board Members) 2 58
Outside directors Board Members 6 66
Total 17 491

*7 Resolution of the General Meeting of Shareholders sets a limit of ¥1 billion on the compensation of directors for one year.
Resolution of the General Meeting of Shareholders sets a limit of ¥300 million on the Compensation of Audit & Supervisory Board Members for one year.

FYE 3/2017
Compensation Committee
Number of Compensation Committee Members Internal directors Male persons 1
Female 0
Total 1
Independent outside directors Male 2
Female 1
Total 3
Total 4
Chairperson of Compensation Committee Internal director
Shareholder rights
Introduction of poison pill None
FYE 3/2015 FYE 3/2016 FYE 3/2017
IR Activities for Institutional Investors and Analysts
Financial results briefing times 2 2 2
Roundtable meeting attended by president, institutional investors, and asset owners companies 34 36 53
IR visit by president in Japan companies 5 6
IR overseas roadshow companies 12 24 46
One-on-one meetings with institutional investors and analysts from Japan and overseas, including telephone interviews times 293 354 363
persons 449 578 606
Conference organized separately by securities company times 21 24 32
persons 27 39 51
Facility tours and briefings on business segment times 2 3 2

* Above date represent the results from the period covering August to July.

Compliance
Whistleblower system Yes
Rule of Whistle-blowing in the company Yes

* We have whistleblower service in-house and outside the company. Users are guaranteed anonymity.